Soe v. Progenity, Inc.

CourtDistrict Court, S.D. California
DecidedDecember 3, 2020
Docket3:20-cv-01683
StatusUnknown

This text of Soe v. Progenity, Inc. (Soe v. Progenity, Inc.) is published on Counsel Stack Legal Research, covering District Court, S.D. California primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
Soe v. Progenity, Inc., (S.D. Cal. 2020).

Opinion

1 2 3 4 5 6 7 8 UNITED STATES DISTRICT COURT 9 SOUTHERN DISTRICT OF CALIFORNIA 10 11 AUNG KYAW SOE, Individually Case No. 20-CV-01683-CAB-AHG and on Behalf of All Others 12 Similarly Situated, ORDER CONSOLIDATING CASES, APPOINTING LEAD PLAINTIFF, 13 Plaintiff, AND APPOINTING CLASS COUNSEL 14 v. [Doc. Nos. 23, 24, 25] 15 PROGENITY, INC., HARRY STYLLI, ERIC D’ESPARBES, 16 JEFFREY ALTER, JOHN BIGALKE, JEFFREY FERRELL, 17 BRIAN L. KOTZIN, SAMUEL NUSSBAUM, LYNNE POWELL, 18 PIPER SANDLER & CO., WELLS FARGO SECURITIES, LLC, 19 ROBERT W. BAIRD & CO. INCORPORATED, RAYMOND 20 JAMES & ASSOCIATES, INC., and BTIG, LLC, 21 Defendants. 22 23 24 Plaintiff Aung Kyaw Soe (hereinafter “Plaintiff”) brings this putative class 25 action complaint (the “Complaint”) alleging violations of the federal securities laws 26 against Defendants Progenity, Inc.; Harry Stylli; Eric d’Esparbes; Jeffrey Alter; John 27 Bigalke; Jeffrey Ferrell; Brian L. Kotzin; Samuel Nussbaum; Lynne Powell; Piper 28 Sandler & Co.; Wells Fargo Securities, LLC; Robert W. Baird & Co. Incorporated; 1 Raymond James & Associates, Inc.; and BTIG, LLC (collectively, “Defendants”). 2 [Doc. No. 1.]1 3 On October 27, 2020, the following parties filed motions seeking 4 consolidation, appointment as lead plaintiff, and approval of their respective 5 selections to be lead counsel: Mohammed Abdul Wajid (“Abdul Wajid”) [Doc. No. 6 23]; Phillip Matz [Doc. No. 24]; and Lin Shen, Lingjun Lin, and Fusheng Lin 7 (together, the “Lin group”) [Doc. No. 25] (the “Competing Motions”). 2 8 On November 17, 2020, the Lin group [Doc. No. 29] and Abdul Wajid [Doc. 9 No. 30] filed oppositions to each other’s Competing Motions. That same day, 10 Defendants filed statements of non-opposition to all Competing Motions, advising 11 that they did not oppose appointment of any lead plaintiff or the proposed 12 consolidation and took no position as to the other relief requested in the Competing 13 Motions. [Doc. Nos. 27, 28.] On November 24, 2020, the Lin group [Doc. No. 31] 14 and Abdul Wajid [Doc. No. 32] filed replies in support of their respective motions. 15 The Court finds the Competing Motions appropriate for resolution without a 16 hearing. After considering the papers filed in support of, and in opposition to, the 17 Competing Motions, the Court GRANTS the Lin group’s motion for lead plaintiff 18 and appointment of counsel [Doc. No. 25], and DENIES both Abdul Wajid’s and 19 Matz’s competing motions [Doc. Nos. 23 and 24], for the reasons outlined below. 20 The Court also GRANTS the parties’ requests to consolidate. 21 I. BACKGROUND 22 Pursuant to the Complaint filed in this matter, Progenity is a biotechnology 23 company based in San Diego, California that “specializes in developing and 24 commercializing molecular testing products and precision medicine applications,” 25 including “in vitro molecular tests designed to assist parents in making informed 26 1 Document numbers and page references are to those assigned by CM/ECF for the docket entry. 27 2 On November 17, 2020, Phillip Matz filed a Notice of Non-Opposition to Competing Motions. [Doc. No. 26.] Accordingly, “Competing Motions” refers to the motions filed by the Lin group 28 1 decisions related to family planning, pregnancy, and complex disease diagnosis.” 2 [Doc. No. 1 at p. 3, ¶ 4.] Plaintiff alleges that Progenity conducted its Initial Public 3 Offering (“IPO”) on June 22, 2020,3 where Defendants sold over 6.6 million shares 4 of Progenity common stock at a price of $15 per share, generating over $100 million 5 in gross offering proceeds. [Id. at p. 3, ¶ 5.] 6 On August 28, 2020, Plaintiff filed the present class action lawsuit against 7 Progenity, certain of its officers and directors, and the underwriters of its IPO, 8 alleging violations of Sections 11 and 15 of the Securities Act of 1933. [Id.] Plaintiff 9 represents a class of those who purchased Progenity common stock pursuant and/or 10 traceable to Progenity’s Registration Statement, issued in connection with its June 11 22, 2020 IPO. [Id. at p. 13, ¶ 39.] Plaintiff alleges that the Registration Statement 12 contained untrue statements of material fact, omitted material facts, and failed to 13 make the necessary disclosures required under the rules governing its preparation, 14 thereby causing damage to the class. [Id. at p. 3, ¶ 6.] Plaintiff seeks to recover 15 damages for Progenity investors. [Id. at p. 16.] 16 On September 11, 2020, Brickman Investments Inc. filed a substantially 17 identical class action lawsuit against Progenity in this district, captioned Brickman 18 Investments Inc. v. Progenity, Inc., et al., Case No. 3:20-cv-01795 (the “Brickman 19 action”). The complaint in the Brickman action alleges three counts for violations of 20 Sections 11, 12, and 15 of the Securities Act of 1933, arising out of Progenity’s 21 issuance of the Registration Statement in connection with its June 22, 2020 IPO. 22 [Brickman Doc. No. 1.] Abdul Wajid also filed a Motion to Consolidate Cases, 23 Appoint Lead Plaintiff, and Appoint Lead Counsel in the Brickman action. 24 [Brickman Doc. No. 10.] On November 24, 2020, the Court issued an Order of 25 Transfer Pursuant to the “Low-Number” Rule, transferring the Brickman action to 26 this Court’s docket. [Brickman Doc. No. 16.] 27 3 In his motion for appointment as lead plaintiff, Abdul Wajid contends that Progenity’s IPO 28 1 II. REQUEST FOR CONSOLIDATION 2 Federal Rule of Civil Procedure 42(a) provides that “when actions involving 3 common questions of law or fact are pending before the court, it . . . may order all 4 the actions consolidated.” FED. R. CIV. P. 42(a). The district court has “broad 5 discretion under this rule to consolidate cases pending in the same district.” Invs. 6 Rsch. Co. v. U.S. Dist. Ct., 877 F.2d 777 (9th Cir. 1989). In determining whether 7 consolidation is appropriate, the district court “weighs the saving of time and effort 8 consolidation would produce against any inconvenience, delay, or expense that it 9 would cause.” Huene v. United States, 743 F.2d 703, 704 (9th Cir. 1984) (subsequent 10 history omitted). The purpose of consolidation is to avoid the unnecessary costs or 11 delays that would ensue from proceeding separately with claims or issues sharing 12 common aspects of law or fact. EEOC v. HBE Corp., 135 F.3d 543, 550 (8th Cir. 13 1998). 14 Additionally, the Private Securities Litigation Reform Act (“PSLRA”) directs 15 that cases should be consolidated when more than one action is filed on behalf of a 16 class asserting substantially the same claim or claims. See In re Cendant Corp. Litig., 17 182 F.R.D. 476, 478 (D. N.J. 1998) (citing 15 U.S.C. § 78u-4(a)(3)(B)(ii)). 15 U.S.C. 18 § 78u-4(a)(3)(B)(ii) also requires that any motions for consolidation be decided first, 19 and that “as soon as practicable” thereafter, the Court “shall appoint the most 20 adequate plaintiff as lead plaintiff for the consolidated actions.” 15 U.S.C. § 78u- 21 4(a)(3)(B)(ii). 22 Here, there are two actions which plaintiffs wish to consolidate: Soe v. 23 Progenity, Inc., Case No. 3:20-cv-01683-CAB-AHG, and Brickman Investments Inc. 24 v. Progenity, Inc., Case No. 3:20-cv-01795-CAB-AHG. All parties moving for 25 appointment as lead plaintiff support consolidation of these two cases. [Doc. No. 23 26 at p. 6; Doc No. 25-1 at p. 6.] Defendants have also indicated that they do not oppose 27 consolidation. [Doc. Nos.

Free access — add to your briefcase to read the full text and ask questions with AI

Related

Cite This Page — Counsel Stack

Bluebook (online)
Soe v. Progenity, Inc., Counsel Stack Legal Research, https://law.counselstack.com/opinion/soe-v-progenity-inc-casd-2020.